These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3660895)

  • 1. [Drugs modifying motility in ulcer therapy].
    Lederer PC; Lux G
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():175-80. PubMed ID: 3660895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokinetic drug treatment (cisapride) is as effective as H2-blocking agent (ranitidine) in the treatment of gastric ulcer.
    Simon B; Bergemann W; Bouzo H; Hüttemann W; Hotz F; Müller P; Rösch W
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():41-5. PubMed ID: 1823066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cisapride and ranitidine as monotherapies and in combination in the treatment of uncomplicated gastric ulceration.
    Stubberöd A; Glise H; Hallerbäck B; Solhaug JH
    Scand J Gastroenterol; 1995 Feb; 30(2):106-10. PubMed ID: 7732330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prokinetic drugs].
    Hellström P
    Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interdigestive gastroduodenal motility in patients with ulcer-like dyspepsia: effect of ranitidine.
    Bortolotti M; Cucchiara S; Sarti P; Brunelli F; Del Campo L; Barbara L
    Hepatogastroenterology; 1992 Feb; 39(1):31-3. PubMed ID: 1568704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
    Dallera F; Scanzi G; Gendarini A
    Clin Ter; 1994 Jan; 144(1):23-6. PubMed ID: 8168347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG; Berstad A
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cisapride in gastric ulcer. Results of a double-blind randomized trial versus ranitidine and versus cisapride plus ranitidine.
    Testoni PA; Bagnolo F; Buizza M; Masci E; Toti GL; Spinelli A; Manzi G
    J Clin Gastroenterol; 1993 Jul; 17(1):5-9. PubMed ID: 8409300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A drive substance for the motor in digestion. Introduction].
    Demling L
    Fortschr Med Suppl; 1990; 87():4. PubMed ID: 2351358
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effects of the combination of traditional Chinese medicine and western medicine on patients with peptic ulcers].
    Zhou B; Li JB; Cai GX; Ling JH; Dai XP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):714-8. PubMed ID: 16708818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conservative therapy of upper gastrointestinal hemorrhage (prospective, randomized, controlled)].
    Stadler H; Giebler A; Tscheliessnigg KH; Berger A; Mischinger HJ
    Wien Med Wochenschr; 1985 Nov; 135(21):533-4, 536-7. PubMed ID: 3878631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prokinetic drugs in digestive disorders].
    Carella G; Marra L
    Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.